Literature DB >> 4936148

New approach to the treatment of hypercalcemia. The effect of short-term treatment with mithramycin.

R E Slayton, B I Shnider, E Elias, J Horton, C P Perlia.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4936148     DOI: 10.1002/cpt1971125833

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  14 in total

Review 1.  The role of antitumor antibiotics in current oncologic practice.

Authors:  H L Davis; D D von Hoff; J E Henney; M Rozencweig
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

2.  Hypocalcaemic response to streptomycin in malignant hypercalcaemia.

Authors:  W E Roediger; D Ludwin; R A Hinder
Journal:  Postgrad Med J       Date:  1975-06       Impact factor: 2.401

3.  Renal handling of calcium and sodium in metastatic and non-metastatic malignancy.

Authors:  S R Heller; D J Hosking
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-01

Review 4.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

Review 5.  [Ectopic paraneoplastic endocrinopathies associated with water-electrolyte balance disorders].

Authors:  K Hayduk; W Kaufmann
Journal:  Klin Wochenschr       Date:  1973-04-15

Review 6.  Drugs for disorders of bone: pharmacological and clinical considerations.

Authors:  G R Mundy; L G Raisz
Journal:  Drugs       Date:  1974       Impact factor: 9.546

Review 7.  [Hypo and hypercalcemia as an emergency].

Authors:  H G Haas; M A Dambacher; J Guncaga
Journal:  Klin Wochenschr       Date:  1975-05-15

Review 8.  Drug interferences with clinical laboratory tests.

Authors:  P P Sher
Journal:  Drugs       Date:  1982-07       Impact factor: 9.546

9.  Quantitation of the renal effect of calcitonin in the hypercalcaemia of malignancy.

Authors:  D J Hosking; S R Heller
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 10.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.